Rac1 Pharmacological Inhibition Rescues Human Endothelial Dysfunction
Open Access
- 1 March 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 6 (3)
Abstract
Background: Endothelial dysfunction contributes significantly to the development of vascular diseases. However, a therapy able to reduce this derangement still needs to be identified. We evaluated the effects of pharmacological inhibition of Rac1, a smallGTPase protein promoting oxidative stress, in human endothelial dysfunction.Methods and Results: We performed vascular reactivity studies to test the effects ofNSC23766, a Rac1 inhibitor, on endothelium‐dependent vasorelaxation of saphenous vein segments collected from 85 subjects who had undergone surgery for venous insufficiency and from 11 patients who had undergone peripheral vascular surgery. The endothelium‐dependent vasorelaxation of the varicose segments of saphenous veins collected from patients with venous insufficiency was markedly impaired and was also significantly lower than that observed in control nonvaricose vein tracts from the same veins. Rac1 activity, reactive oxygen species levels, and reduced nicotine adenine dinucleotide phosphate (NADPH) oxidase activity were significantly increased in varicose veins, andNSC23766 was able to significantly improve endothelium‐dependent vasorelaxation of dysfunctional saphenous vein portions in a nitric oxide–dependent manner. These effects were paralleled by a significant reduction ofNADPHoxidase activity and activation of endothelial nitric oxide synthase. Finally, we further corroborated this data by demonstrating that Rac1 inhibition significantly improves venous endothelial function and reducesNADPHoxidase activity in saphenous vein grafts harvested from patients with vascular diseases undergoing peripheral bypass surgery.Conclusions: Rac1 pharmacological inhibition rescues endothelial function and reduces oxidative stress in dysfunctional veins. Rac1 inhibition may represent a potential therapeutic intervention to reduce human endothelial dysfunction and subsequently vascular diseases in various clinical settings.Keywords
This publication has 36 references indexed in Scilit:
- The Vascular Endothelium and Human DiseasesInternational Journal of Biological Sciences, 2013
- NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studiesBasic Research in Cardiology, 2011
- NADPH Oxidases: Functions and Pathologies in the VasculatureArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Pressure-Induced Vascular Oxidative Stress Is Mediated Through Activation of Integrin-Linked Kinase 1/βPIX/Rac-1 PathwayHypertension, 2009
- Tumor Necrosis Factor-α Mediates Hemolysis-Induced Vasoconstriction and the Cerebral Vasospasm Evoked by Subarachnoid HemorrhageHypertension, 2009
- Endothelial Function Impairment in Chronic Venous Insufficiency: Effect of Some Cardiovascular Protectant AgentsAngiology, 2009
- Regulation of Endothelial Nitric Oxide Synthase and Postnatal Angiogenesis by Rac1Circulation Research, 2008
- An essential role for Rac1 in endothelial cell function and vascular developmentThe FASEB Journal, 2008
- Regulation of NADPH OxidasesCirculation Research, 2006
- Rho GTPase/Rho Kinase Negatively Regulates Endothelial Nitric Oxide Synthase Phosphorylation through the Inhibition of Protein Kinase B/Akt in Human Endothelial CellsMolecular and Cellular Biology, 2002